EA200400997A1 - METHOD THAT PROVIDES PREVENTION OF TUBERCULOSIS IN HIV-POSITIVE INDIVIDUALS - Google Patents

METHOD THAT PROVIDES PREVENTION OF TUBERCULOSIS IN HIV-POSITIVE INDIVIDUALS

Info

Publication number
EA200400997A1
EA200400997A1 EA200400997A EA200400997A EA200400997A1 EA 200400997 A1 EA200400997 A1 EA 200400997A1 EA 200400997 A EA200400997 A EA 200400997A EA 200400997 A EA200400997 A EA 200400997A EA 200400997 A1 EA200400997 A1 EA 200400997A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hiv
tuberculosis
positive individuals
provides prevention
present
Prior art date
Application number
EA200400997A
Other languages
Russian (ru)
Inventor
Раджив Индравадан Моди
Бакулиш Мафатлал Хамар
Original Assignee
Раджив Индравадан Моди
Бакулиш Мафатлал Хамар
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Раджив Индравадан Моди, Бакулиш Мафатлал Хамар filed Critical Раджив Индравадан Моди
Publication of EA200400997A1 publication Critical patent/EA200400997A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

Настоящее изобретение относится к способу, обеспечивающему профилактику туберкулёза у ВИЧ-положительных индивидов. В соответствии с настоящим изобретением обнаружено, что вакцина, выполненная из Myco-bacterium w (Mw), полезна при обеспечении профилактики туберкулёза у ВИЧ-положительных индивидов.The present invention relates to a method for preventing tuberculosis in HIV-positive individuals. In accordance with the present invention, it has been found that a vaccine made from Myco-bacterium w (Mw) is useful in ensuring prevention of tuberculosis in HIV-positive individuals.

EA200400997A 2002-01-29 2003-01-27 METHOD THAT PROVIDES PREVENTION OF TUBERCULOSIS IN HIV-POSITIVE INDIVIDUALS EA200400997A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN81MU2002 2002-01-29
PCT/IB2003/000207 WO2003063897A1 (en) 2002-01-29 2003-01-27 Method of providing prophylaxis for tuberculosis in hiv positive individuals

Publications (1)

Publication Number Publication Date
EA200400997A1 true EA200400997A1 (en) 2005-12-29

Family

ID=27638225

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200400997A EA200400997A1 (en) 2002-01-29 2003-01-27 METHOD THAT PROVIDES PREVENTION OF TUBERCULOSIS IN HIV-POSITIVE INDIVIDUALS

Country Status (8)

Country Link
EP (1) EP1478391A1 (en)
JP (1) JP2006502090A (en)
AP (1) AP2004003109A0 (en)
BR (1) BR0307262A (en)
CA (1) CA2474794A1 (en)
EA (1) EA200400997A1 (en)
GB (1) GB2400560A (en)
WO (1) WO2003063897A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003209534A1 (en) * 2002-03-08 2003-09-22 Bakulesh Mafatlal Khamar The method of treating tuberculosis
ES2231037B1 (en) 2003-10-31 2005-12-16 Archivel Technologies, Sl USEFUL IMMUNOTHERAPIC AGENT FOR THE COMBINED TREATMENT OF TUBERCULOSIS IN ASSOCIATION WITH OTHER PHARMACOS.
ES2307402B1 (en) * 2006-10-30 2009-09-30 Archivel Farma, S.L. PROFILACTIC VACCINE AGAINST TUBERCULOSIS.
EP2170083A4 (en) * 2007-06-28 2011-09-28 Cadila Pharmaceuticals Ltd Mitogen activated protein kinase modulator

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9219425D0 (en) * 1992-09-14 1992-10-28 Univ London Therapeutic agent and its use
GB8918206D0 (en) * 1989-08-09 1989-09-20 Nat Inst Immunology Tuberculosis vaccine
WO2003075824A2 (en) * 2002-03-08 2003-09-18 Modi, Rajiv, Indravadan Process of manufacturing pharmaceutical composition useful for management of tuberculosis

Also Published As

Publication number Publication date
GB0418776D0 (en) 2004-09-22
CA2474794A1 (en) 2003-08-07
GB2400560A (en) 2004-10-20
AP2004003109A0 (en) 2004-09-30
JP2006502090A (en) 2006-01-19
WO2003063897A8 (en) 2005-03-31
WO2003063897A1 (en) 2003-08-07
EP1478391A1 (en) 2004-11-24
BR0307262A (en) 2006-12-19

Similar Documents

Publication Publication Date Title
IL249263B (en) Method for ex-vivo organ care
ATE426412T1 (en) ADJUVANT INFLUENZA VACCINE
DK1562444T3 (en) Process for reducing the acrylamide content of heat-treated foods
HN2003000227A (en) KINASE INHIBITORS
GB2432537A (en) A ciliated stent-like system
EP1485360A4 (en) Sodium channel blockers
NO20064547L (en) Methods for treating HIV infection
EA200700904A1 (en) VACCINES AGAINST THE JAPANESE ENCEPHALITE VIRUS AND WESTERN NILE VIRUS
TW200519089A (en) Biaryl sulfonamides and methods for using same
NO20052149D0 (en) Vaccine.
TW200518769A (en) Use of calcitonin in osteoarthritis
TW200726479A (en) Method of inducing neutralizing antibodies to human immunodeficiency virus
TW200519100A (en) Biaryl sulfonamides and methods for using same
ATE330017T1 (en) KALLIKREIN GEN
CY1108599T1 (en) APLIDIN IN TREATMENT OF MULTIPLE MYELOMA
EA200601029A1 (en) METHOD OF CLEANING FSH
DK1471936T3 (en) HIV Vaccine and Method of Use
WO2003103481A3 (en) Methods for detecting b. anthracis infection
ATE530982T1 (en) USB DEVICE
ITMI20022022A1 (en) ANALOGUES OF NOCICETTINA.
ATE382778T1 (en) PUMP COMBINATION
EA200400997A1 (en) METHOD THAT PROVIDES PREVENTION OF TUBERCULOSIS IN HIV-POSITIVE INDIVIDUALS
MY141820A (en) A system and associated method to determine authentication priority between devices
PL376130A1 (en) Controlled releases system containing temozolomide
AU2003255611A1 (en) Novel antiretroviral sulpholipids extracted from spirulinae, method for obtaining same, compositions containing same and use thereof as inhibitors of the hiv virus reverse transcriptase